Medical Testing

J&J says Covid booster shot is 94% effective when given 2 months after first dose

Submitted by mike kraft on Tue, 2021-09-21 09:51

J&J says Covid booster shot is 94% effective in the U.S. when given two months after first dose A J&J booster dose given six months out from the first shot appears to be potentially even more protective against Covid, the company added. Berkeley Lovelace Jr. CNBC

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about J&J says Covid booster shot is 94% effective when given 2 months after first dose
Log in or register to post comments

CDC recommends waiting period for Afghan flights to U.S. after measles cases

Submitted by mike kraft on Mon, 2021-09-20 18:56

CDC recommends waiting period for Afghan flights to U.S. after measles cases The CDC announced that it would halt flights to the U.S. for Afghan evacuees for at least a week out of an abundance of caution. Erin Banco POLITICO

The Centers for Disease Control and Prevention is recommending the Biden administration halt flights of Afghan evacuees from military bases overseas to the U.S. for at least 21 days following a measles vaccination, according to two people with direct knowledge of the matter.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about CDC recommends waiting period for Afghan flights to U.S. after measles cases
Log in or register to post comments

FDA expected to OK Pfizer boosters for older Americans this week

Submitted by mike kraft on Mon, 2021-09-20 11:19

Regulators expected to OK Pfizer boosters for older Americans this week U.S. regulators are expected to authorize a third booster shot of the Pfizer Inc /BioNTech SE COVID-19 vaccine for older and some high-risk Americans early this week in time for the government to roll them out by Friday as hoped. Michael Erman Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA expected to OK Pfizer boosters for older Americans this week
Log in or register to post comments

Pfizer says its COVID-19 vaccine is safe, effective in kids ages 5 to 11

Submitted by mike kraft on Mon, 2021-09-20 07:36

Pfizer/BioNTech data shows COVID-19 vaccine safe and protective in kids Pfizer Inc and BioNTech SE said on Monday their COVID-19 vaccine induced a robust immune response in 5 to 11 year olds, and they plan to ask for authorization to use the vaccine in children in that age range in the United States, Europe and elsewhere as soon as possible. Michael Erman Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Pfizer says its COVID-19 vaccine is safe, effective in kids ages 5 to 11
Log in or register to post comments

CDC: One-third in 'limited' study report long-term COVID-19 two months after positive test

Submitted by mike kraft on Fri, 2021-09-17 12:35

CDC: One-third in 'limited' study report long-term COVID-19 two One-third of participants in a California study said they experienced at least one longer-term COVID-19 symptom two months after testing positive, according to a study published Thursday, as Justine Coleman TheHill

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about CDC: One-third in 'limited' study report long-term COVID-19 two months after positive test
Log in or register to post comments

British study to test mixed COVID-19 vaccine dose schedules in children

Submitted by mike kraft on Fri, 2021-09-17 11:00

British study to test mixed COVID-19 vaccine dose schedules in children A British study will look into the immune responses of children to mixed schedules of different COVID-19 vaccines as officials try to determine the best approach to second doses in adolescents given a small risk of heart inflammation. Alistair Smout Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about British study to test mixed COVID-19 vaccine dose schedules in children
Log in or register to post comments

Researchers looking into whether COVID-19 hybrid immunity could be a potential pandemic game-changer

Submitted by mike kraft on Fri, 2021-09-17 10:40

How COVID-19 hybrid immunity could be a potential pandemic game-changer "The best thing we can hope for is that three vaccine doses will emulate the super immune response, found among those previously infected with the virus," said Dr. Paul Goepfert, an infectious disease physician and director of the Alabama Vaccine Research Clinic. "This [type of immunity] will protect against variants in the future." With the nation still slogging through the pandemic and contending with the delta variant’s threat of breakthrough infections, "super immunity" becomes an appealing concept. DR. L.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Read more about Researchers looking into whether COVID-19 hybrid immunity could be a potential pandemic game-changer
Log in or register to post comments

Measles concerns among Afghan refugees may delay Afghan resettlement by weeks

Submitted by mike kraft on Tue, 2021-09-14 17:51

Measles concerns may delay Afghan resettlement by weeks The Biden administration announced that it would halt flights for Afghan evacuees at the Ramstein Air Base in Germany and the Al Udeid Air Base in Qatar after four individuals tested positive following their arrival. Erin Banco POLITICO

The Centers for Disease Control and Prevention is recommending Afghan evacuees housed at U.S. military bases overseas be tested and vaccinated for measles — a process that could delay efforts to resettle as many as 12,000 by several weeks, according to three senior administration officials.

Country / Region Tags:

General Topic Tags: